Man faints in Oval Office as Trump unveils drug price update

A pharmaceutical executive collapsed in the Oval Office Thursday as members of the Trump administration were announcing a new deal for weight-loss medications.

The man was standing behind President Donald Trump during the event when his knees appeared to suddenly buckle underneath him. Reporters initially identified the man as Novo Nordisk executive Gordon Finlay however the company later denied that it was him.

Reporters who witnessed the incident first-hand said Dr. Mehmet Oz, Administrator for Centers for Medicare & Medicaid Services, helped the executive to the ground, preventing the man from hitting his head. As reporters were ushered out of the Oval Office, Cabinet members attended to the man, elevating his legs.

White House Press Secretary Karoline Leavitt said in a statement: “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”

Thursday’s press conference featured executives from drug makers, Novo Nordisk and Eli Lilly, which have worked with the administration on a deal to make weight loss medications, known as GLP-1s, more affordable.